Psychometric validation of the Brain Symptom and Impact Questionnaire (BASIQ) version 1.0 to assess quality of life in patients with brain metastases-Reference-Cited by-同舟云学术

Psychometric validation of the Brain Symptom and Impact Questionnaire (BASIQ) version 1.0 to assess quality of life in patients with brain metastases

Published:2015-01 Issue:1 Volume:4 Page:11-23
ISSN:2045-0907
Container-title:CNS Oncology
language:en
Short-container-title:CNS Oncology

Author:

Thavarajah Nemica¹,Ray Saurabh²,Bedard Gillian¹,Zhang Liying¹,Cella David³,Wong Erin¹,Danjoux Cyril¹,Tsao May¹,Barnes Elizabeth¹,Sahgal Arjun¹,Soliman Hany¹,Pulenzas Natalie¹,Lechner Breanne¹,Chow Edward¹

Affiliation:

1. Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, M4N3M5 Canada

2. Oncology AbbVie, Abbott Park, IL, USA

3. Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Abstract

SUMMARY Objective: To test the reliability, clinical and psychometric validity of the Brain Symptom and Impact Questionnaire (BASIQ) in patients with brain metastases. Methods: Brain metastases patients were interviewed using the BASIQ, Functional Assessment of Cancer-Brain (FACT-Br) and FACT-General (FACT-G) at baseline, with a follow-up assessment at 1 month. Results: Forty patients had complete one data and the median age was 64 years. Patients with higher KPS, ECOG of 2, primary breast cancer, or >3 brain metastases, scored higher on the symptom scale of the BASIQ. All subscales showed no significant change in patient symptoms from baseline to follow-up. Conclusion: This study supports that the reliability, clinical and psychometric validity of BASIQ to be used in brain metastases patients.

Publisher

Future Medicine Ltd

Subject

General Medicine

Link

https://www.futuremedicine.com/doi/pdf/10.2217/cns.14.49

Reference21 articles.

1. Molecular MRI enables early and sensitive detection of brain metastases

2. Quality of Life in Patients with Brain Metastases Treated with a Palliative Course of Whole-Brain Radiotherapy

3. Modern Multidisciplinary Management of Brain Metastases

4. Multidisciplinary Management of Brain Metastases

5. A PILOT STUDY OF NEUROCOGNITIVE FUNCTION IN PATIENTS WITH ONE TO THREE NEW BRAIN METASTASES INITIALLY TREATED WITH STEREOTACTIC RADIOSURGERY ALONE

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of the BC-Brain Patient-Reported Outcome Questionnaire for Patients with Central Nervous System Tumours Treated with Radiotherapy;Current Oncology;2022-04-16

2. Quality of reporting and assessment of patient-reported health-related quality of life in patients with brain metastases: a systematic review;Neuro-Oncology Practice;2018-07-19

3. Effect of Brain Metastasis on Patient-Reported Outcomes in Advanced NSCLC Treated in Real-World Community Oncology Settings;Clinical Lung Cancer;2018-03

4. Measuring health-related quality of life in patients with advanced cancer: a systematic review of self-administered measurement instruments;Quality of Life Research;2018-02-10

5. Quality of life with Brain Symptom and Impact Questionnaire in patients with brain metastases;Annals of Palliative Medicine;2016-07